Driving Lead Optimization:

In-silico drug design not only aids in identifying potential drug candidates but also contributes to lead optimization. By utilizing computational methods, researchers can explore different chemical modifications and structural variations to optimize the drug’s properties, including potency, selectivity, and pharmacokinetic profiles. This iterative process helps refine the lead compounds and increases the chances of success in subsequent experimental validations.